Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Drug Development
  • Published:

Doppelgänger proteins as drug leads

The mirror-image world of dextrorotary D proteins is providing researchers with new ways to think about making therapeutics.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Del Milton, R.C., Milton, S.C., and Kent, S.B.H. 1992. Science 256: 1445–1448.

    Article  Google Scholar 

  2. Dintzis H.M. et al. 1993 Proteins: Structure, Function, Genetics 16: 306–308.

    Article  CAS  Google Scholar 

  3. Schumacker T.N.M. et al. 1996. Science 271: 1854–1857.

    Article  Google Scholar 

  4. Mui T.W. et al. 1994. Biochemistry 33: 7701–7708.

    Article  Google Scholar 

  5. Zuwadzke L.E. and Berg J.M. 1993. Proteins: Structure, Function, Genetics 16: 301–305.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robson, B. Doppelgänger proteins as drug leads. Nat Biotechnol 14, 892–893 (1996). https://doi.org/10.1038/nbt0796-892

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0796-892

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing